Hypertriglyceridemia: all 302 studies

Page 3 of 4. Open to participants first (38), then studies with results posted, then the rest; newest registration first within each.

• Compassionate Use of Metreleptin in Previously Treated People With Partial LipodystrophyActive, not recruitingNCT02262806Phase 2
• Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) HypertriglyceridemiaCompletedNCT02250105Phase 2
• Supplementation of Dual Probiotic Strains Reduced Fasting Triglyceride and Enhanced Apolipoprotein A-V LevelsCompletedNCT02215694Phase 3
• PK Study Comparing Metformin Eicosapentaenoate to a Combined Dose of Metformin Hydrochloride and Ethyl Ester EPACompletedNCT02113163Phase 1
• Pilot Study To Assess CAT-2003 in Patients With ChylomicronemiaCompletedNCT02098278Phase 2
• Apolipoprotein CIII Reduction Via ColchicineCompletedNCT02083510Early Phase 1
• Supplementation With Omega-3: Mechanism of ActionTerminatedNCT02036307Phase 2
• Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus and Acute Coronary SyndromeStatus unknownNCT02015988Phase 4
• A Pilot Study to Evaluate the Lipid Effects of TRIA-662CompletedNCT02008084Phase 2
• Effect of DHA on Lipid and Carbohydrate Metabolism Alterations and Body Fat Distribution in HIV Patients Under HAART.CompletedNCT02005900Phase 3
• The Efficacy of EPA+DHA (SC401B) for Lowering Triglyceride Levels (≥ 500 mg/dL)WithdrawnNCT01997268Phase 3
• Pilot Study To Assess CAT-2003 in Patients With Severe HypertriglyceridemiaCompletedNCT01968720Phase 2
• Pilot Study To Assess CAT-2003 in Patients With HyperlipidemiaCompletedNCT01912560Phase 2
• Bioavailability of EPA and DHA From Two Dietary SupplementsStatus unknownNCT01908374Not applicable
• Effects Of Consumption Of A Highly Mineralized Sodium Bicarbonated Water On Blood Lipid ProfileCompletedNCT01819636Not applicable
• Consumption of Whole Grains and Legumes Modulates the Genetic Effect of the APOA5 -1131C VariantCompletedNCT01784952Not applicable
• Study to Assess the Safety and Tolerability of Single Doses of REGN1500CompletedNCT01749878Phase 1
• Efficacy and Safety Study of DHA-O in Adults With HypertriglyceridemiaCompletedNCT01737099Not applicable
• An Efficacy and Safety Study of Omacor® in Taiwanese Hypertriglyceridemic PatientsCompletedNCT01725646Phase 3
• The Effect of Phytosterol Esters of Omega-3 (Vayarol) Versus Omega-3 Acids Ethyl Esters in Reducing Triglyceride LevelsCompletedNCT01712867Not applicable
• Vascular and Metabolic Effects of Fenofibrate/Omega vs FenofibrateCompletedNCT01666041Phase 4
• Vascular and Metabolic Effects of Omega-3 Fatty AcidsCompletedNCT01660932Phase 4
• Crocus Sativus (Saffron) and Berberis Vulgaris (Barberry Fruit) in Metabolic SyndromeCompletedNCT01625442Phase 4
• A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe HypertriglyceridemiaCompletedNCT01594983Phase 2
• Postprandial Lipid Metabolism in Familial Hypercholesterolaemia:Effects of Fish OilsStatus unknownNCT01577056Not applicable
• Carbohydrate Metabolism Disorder Frequency in Hypertriglyceridemia Induced by Bexarotene of Cutaneous T Cell LymphomaCompletedNCT01569724Phase 4
• Combined Effects of Bioactive Compounds in Lipid ProfileCompletedNCT01562080Phase 2/3
• Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver DiseaseCompletedNCT01556113Not applicable
• A Clinical Trial to Evaluate the Safety and Efficacy of ZYH7 Compared to Fenofibrate in Patients With DyslipidemiaCompletedNCT01539616Phase 2
• Safety, Tolerability, and Pharmacokinetic Study of ISIS ApoC-III Rx in HypertriglyceridemiaCompletedNCT01529424Phase 2
• Effects of DPP-4 Inhibition on TriglyceridesSuspendedNCT01527747Phase 4
• Assess the Safety and Efficacy of NKPL66 (CaPre™) in the Treatment of Mild-to-high HypertriglyceridemiaCompletedNCT01516151Phase 2
• The Effect of Multiple Doses of Epanova® on the Multiple-Dose Pharmacokinetics of Simvastatin in Healthy Normal SubjectsCompletedNCT01486433Phase 1
• Fish Oil Supplementation and Vascular Function in Hypertensive Patients With HypertriglyceridemiaStatus unknownNCT01480687Phase 4
• Chinese Medicine Treatment of Obesity With Type 2 Diabetes, DyslipidemiaStatus unknownNCT01471275Not applicable
• TRIal For Efficacy of Capre on hyperTriglyceridemiACompletedNCT01455844Phase 2
• Intervention With n-3 Polyunsaturated Fatty Acids (PUFA)-Supplemented Products in Moderate Hypertriglyceridemic PatientsCompletedNCT01437930Not applicable
• Interaction of Epanova on Warfarin Pharmacokinetic and Anticoagulant Activity and Comparison of the Effects of Epanova and Lovaza on Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) After Low-fat MealsCompletedNCT01431690Phase 1
• Lovaza Mechanisms of ActionStatus unknownNCT01301794Phase 4
• Pioglitazone Attenuates Dysmetabolism in Peritoneal Dialysis (PD) PatientsCompletedNCT01258322Not applicable
• Efficacy Study to Treat Subjects With Severe HypertriglyceridemiaStatus unknownNCT01229566Phase 3
• Efficacy Study of Diazoxide Choline to Treat HypertriglyceridemiaCompletedNCT01211847Phase 2
• Elevated Triglyceride Levels and Later Type 2 DiabetesCompletedNCT01182935
• Effects of Lovaza on High Density Lipoprotein (HDL) Composition and Function in HypertriglyceridemiaWithdrawnNCT01180764Phase 4
• Effects of Amino Acids on Regional Lipid MetabolismCompletedNCT01150188Not applicable
• The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy VolunteersCompletedNCT01148004Phase 1
• Safety, Tolerability,Pharmacokinetics(PK)and Pharmacodynamics(PD)Assessment of LCQ908 in Patients With Severe HypertriglyceridemiaCompletedNCT01146522Phase 1/2
• Effect of Maraviroc on Metabolic Function in Obese Subjects (Phase I)CompletedNCT01133210Phase 1
• Effects of Omega-3 Fatty Acids on Markers of InflammationCompletedNCT01129050Not applicable
• Comparison of Fenofibrate and Niacin in Patients With Hypertriglyceridemia and Low High-Density Lipoprotein (HDL)-CholesterolCompletedNCT01122355Phase 4
• Omega-3 Fatty Acid Supplementation in ChildrenCompletedNCT01088776Phase 2
• Effects of Omega-3 Fatty Acids on Platelets in Patients With Coronary Artery Disease With HypertriglyceridemiaStatus unknownNCT01086163
• Predictors of Response to FenofibrateCompletedNCT01023750
• Differential Metabolic Effects of Fenofibrate and Fatty AcidCompletedNCT01003847Phase 4
• Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High TriglyceridesWithdrawnNCT00973271Phase 3
• A Pilot Study to Determine the Efficacy of a Low Carbohydrate Diet in Treatment of Adolescents With Metabolic SyndromeCompletedNCT00940966Not applicable
• Effects of Monascus Garlic Fermented Extract on Serum Triglyceride LevelCompletedNCT00938249Not applicable
• Beef in an Optimal Lean Diet (BOLD) Effects on Cardiovascular Disease (CVD) RiskCompletedNCT00937898Not applicable
• Triglyceride Lowering StudyStatus unknownNCT00934219Phase 4
• Open-Label, Single- and Multiple-Dose Pharmacokinetic Study of Diazoxide CholineWithdrawnNCT00901823Phase 1
• Effect of Fish Oil on Plasma Triglycerides in AdultsCompletedNCT00804427Not applicable
• The Effects of Omega-3 Fatty Acid (OMACOR) on the Low-density Lipoprotein (LDL) Sub-fraction in Type 2 Diabetic PatientsStatus unknownNCT00758927Phase 4
• Effects of Fenofibrate on Adipocytokine Levels In Hypertriglyceridemic PatientsCompletedNCT00745407Phase 4
• Docosahexenoic Acid (DHA) Supplementation and Cardiovascular Disease in Men With High TriglyceridesCompletedNCT00728338Not applicable
• Diazoxide Choline in HypertriglyceridemiaCompletedNCT00696475Phase 2
• Effect of Omega-3 Fatty Acid Supplementation on Hypertriglyceridemia in HIV-infected ChildrenTerminatedNCT00691288Phase 2
• Open-label Pharmacokinetic Study of Diazoxide Choline Coated vs. Uncoated FormulationsCompletedNCT00688857Phase 1
• Expanded Access for Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With LipodystrophyNo longer availableNCT00677313
• Changes in Blood Lipids After Long-term Consumption of n-3 LC-PUFA-Enriched Dairy ProductsCompletedNCT00639041Not applicable
• Pharmacological Regulation of Fat Transport in Metabolic SyndromeCompletedNCT00632840Phase 4
• Effect of Omacor on Triglycerides in HIV Infected SubjectsTerminatedNCT00598910Phase 4
• Effect of Changing Diet on Fasting and Post Fat Load LipoproteinsCompletedNCT00593424Not applicable
• Evaluation of Safety and Effects of SLx-4090 After Dosing for 14 Days in Subjects With High TriglyceridesCompletedNCT00562575Phase 2
• Regulation of Inflammatory Parameters by Telmisartan in Hypertensive PatientsCompletedNCT00560430Phase 3
• Effect of Soluble Fiber on Hypertriglyceridemia and Immune Profile in HIV-positive Individuals.CompletedNCT00540111Not applicable
• Fructose-Induced Palmitate Synthesis in Overweight SubjectsCompletedNCT00535535Phase 1
• A Study to Evaluate the Lipid Regulating Effects of 1-Methylnicotinamide (1-MNA)CompletedNCT00519714Phase 2/3
• Novel Therapies for Metabolic Complications of LipodystrophiesCompletedNCT00457938Not applicable
• Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and ThrombosisCompletedNCT00422396Not applicable
• Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD PatientsWithdrawnNCT00397358Phase 4
• The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or DiabetesCompletedNCT00360217Not applicable
• Laparoscopic Adjustable Gastric Banding With Truncal VagotomyTerminatedNCT00329862Not applicable
• Fat Tolerance From Lipid Emulsion Infusion Packaged in Glass or PlasticTerminatedNCT00278928Not applicable
• Evaluation of Efficacy and Safety of Combined Omacor (Omega-3-acid Ethyl Esters) and Simvastatin Therapy in Hypertriglyceridemic SubjectsCompletedNCT00246701Phase 3
• Evaluation of Efficacy and Safety of Omacor (Omega-3-acid Ethyl Esters) as Add-on Therapy in Hypertriglyceridemic Subjects Treated With Antara (Fenofibrate) Followed by an 8-week ExtensionCompletedNCT00246636Phase 4
• Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIVCompletedNCT00246402Not applicable
• A Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With DyslipidemiaTerminatedNCT00231621Phase 3
• A Study Comparing The Efficacy & Safety Of Torcetrapib/Atorvastatin And Atorvastatin In Subjects With High TriglyceridesCompletedNCT00134498Phase 3
• Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug TherapyCompletedNCT00109603Not applicable
• Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and TriglyceridesCompletedNCT00108511Phase 1
• A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)CompletedNCT00093899Phase 3
• Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED)CompletedNCT00092573Phase 3
• Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)CompletedNCT00092560Phase 3
• Pharmacogenetics of Hypertriglyceridemia in HispanicsCompletedNCT00086437
• Implitapide in Patients With Hypertriglyceridemia (HTG) on Maximal, Concurrent Triglyceride-Lowering TherapyTerminatedNCT00080132Phase 2
• The Effect of Fish Oil Plus Fenofibrate on Triglyceride Levels in People Taking Highly Active Antiretroviral Therapy (HAART)CompletedNCT00076518Phase 2
• Genetic Determinants:Low HDL, High Triglycerides, ObesityCompletedNCT00049881
• Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected PatientsCompletedNCT00046267Not applicable
• Garlic in Hyperlipidemia Caused by HAARTWithdrawnNCT00029250Phase 2
• Rosiglitazone and Exercise Training: Effects on HIV-Infected People With Insulin Resistance, Hypertriglyceridemia, and Adipose Tissue MaldistributionCompletedNCT00025753Not applicable

← Hypertriglyceridemia overview